Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination.

Wen-Man ZhaoRui ShiPeng WangJun HeYue ChenYa-Ting FengHai-Feng PanDe-Guang Wang

Published in: Journal of inflammation research (2022)

The seroprevalences of IgG and IgM antibodies against SARS-CoV-2 and vaccination-related adverse effects are similar between HD and HCs. The inactivated SARS-CoV-2 vaccine is effective and safe in inducing near-term immunity in hemodialysis patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
immune response
preterm infants
coronavirus disease